Neonatal lupus syndromes;Le lupus néonatal

Archives de Pediatrie

Volumn 13, Issue 5, 2006, Pages 473-478

  Cimaz, R ^a   Duquesne, A ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

congenital; Infant; Lupus; newborn

Indexed keywords

BETAMETHASONE; CORTICOSTEROID; DEXAMETHASONE; LA ANTIBODY; LIVER ENZYME; RO ANTIBODY; SALBUTAMOL;

ANEMIA; APOPTOSIS; ATRIOVENTRICULAR BLOCK; CLINICAL FEATURE; CLINICAL TRIAL; CONGENITAL HEART MALFORMATION; ECHOCARDIOGRAPHY; ECHOGRAPHY; ELECTROCARDIOGRAPHY; ENVIRONMENTAL FACTOR; HUMAN; LABORATORY TEST; LUPUS ERYTHEMATOSUS; OUTCOME ASSESSMENT; PATHOGENESIS; PREGNANCY; PREVALENCE; PROGNOSIS; PROPHYLAXIS; QT PROLONGATION; RASH; RISK ASSESSMENT; SHORT SURVEY; SINUS BRADYCARDIA; THROMBOCYTOPENIA; TISSUE INJURY;

HUMANS; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, SYSTEMIC; PROGNOSIS;

EID: 33646121996     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2005.12.012     Document Type: Short Survey

References (39)

1. Buyon J.P., Rupel A., and Clancy R.M. Neonatal lupus syndromes. Lupus 13 (2004) 705-712
2. Brucato A., Cimaz R., Catelli L., et al. Anti-Ro associated sinus bradycardia in newborns. Circulation 102 (2000) E88-E89 [letter]
3. Cimaz R., Airoldi M.L., Careddu P., et al. Transient neonatal bradycardia without heart block associated with anti-Ro antibodies. Lupus 6 (1997) 487-488
4. Cimaz R., Stramba-Badiale M., Brucato A., et al. QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block. Arthritis Rheum. 43 (2000) 1049-1053
5. Schwartz P.J., Stramba-Badiale M., Segantini A., et al. Prolongation of the QT interval and the sudden infant death syndrome. N. Engl. J. Med. 338 (1998) 1709-1714
6. Cimaz R., Meroni P.L., Brucato A., et al. Concomitant disappearance of electrocardiographic abnormalities and of acquired maternal autoantibodies during the first year of life in infants who had QT interval prolongation and anti-SSA/Ro positivity without congenital heart block at birth. Arthritis Rheum. 48 (2003) 266-268
7. Moak J.P., Barron K.S., Hougen T.J., et al. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J. Am. Coll. Cardiol. 37 (2001) 238-242
8. Udink T., Cate F.E., Breur J.M., et al. Dilated cardiomyopathy in isolated congenital complete atrioventricular block: early and long-term risk in children. J. Am. Coll. Cardiol. 37 (2001) 1129-1134
9. Weston W.L., Morelli J.G., and Lee L.A. The clinical spectrum of anti-Ro-positive cutaneous neonatal lupus erythematosus. J. Am. Acad. Dermatol. 40 (1999) 675-681
10. Neiman A.R., Lee L.A., Weston W.L., et al. Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry. J. Pediatr. 137 (2000) 674-680
11. Cimaz R., Spence D.L., Hornberger L., et al. Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies. J. Pediatr. 142 (2003) 678-683
12. Michaelsson M., Jonzon A., and Riesenfeld T. Isolated congenital complete atrioventricular block in adult life. A prospective study. Circulation 92 (1995) 442-449
13. Cimaz R., Catelli L., Luzzana C., et al. Neonatal lupus syndromes. Isr. Med. Assoc. J. 2 (2000) 228-231
14. Brucato A., Frassi M., Franceschini F., et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis. A prospective study of 100 women. Arthritis Rheum. 44 (2001) 1832-1835
15. Reichlin M., Brucato A., Frank M.B., et al. Concentration of autoantibodies to native 60-kd Ro/SS-A and denatured 52-kd Ro/SS-A in eluates from the heart of a child who died with congenital complete heart block. Arthritis Rheum. 37 (1994) 1698-1703
16. Fesslova V., Mannarino S., Salice P., et al. Neonatal lupus: fetal myocarditis progressing to atrioventricular block in triplets. Lupus 12 (2003) 775-778
17. Alexander E., Buyon J.P., Provost T.T., et al. Anti-Ro/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model. In vitro electrophysiologic and immunocytochemical studies. Arthritis Rheum. 35 (1992) 176-189
18. Garcia S., Nascimento J.H., Bonfa E., et al. Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts. J. Clin. Invest. 93 (1994) 718-724
19. Boutjdir M., Chen L., Zhang Z.H., et al. Arrhythmogenicity of IgG and anti-52-kD SSA/Ro affinity-purified antibodies from mothers of children with congenital heart block. Circ. Res. 80 (1997) 354-362
20. Xiao G.Q., Hu K., and Boutjdir M. Direct inhibition of expressed cardiac l- and t-type calcium channels by IgG from mothers whose children have congenital heart block. Circulation 103 (2001) 1599-1604
21. Boutjdir M., Chen L., Zhang Z.H., et al. Serum and immunoglobulin G from the mother of a child with congenital heart block induce conduction abnormalities and inhibit L-type calcium channels in a rat heart model. Pediatr. Res. 44 (1998) 11-19
22. Mazel J.A., El Sherif N., Buyon J., et al. Electrocardiographic abnormalities in a murine model injected with IgG from mothers of children with congenital heart block. Circulation 99 (1999) 1914-1918
23. Solomon D.G., Rupel A., and Buyon J.P. Birth order, gender and recurrence rate in autoantibody-associated congenital heart block: implications for pathogenesis and family counseling. Lupus 12 (2003) 646-647
24. Stevens A.M., Hermes H.M., Rutledge J.C., et al. Myocardial-tissue-specific phenotype of maternal microchimerism in neonatal lupus congenital heart block. Lancet 362 (2003) 1617-1623
25. Stevens A.M., Hermes H.M., Lambert N.C., et al. Maternal and sibling microchimerism in twins and triplets discordant for neonatal lupus syndrome-congenital heart block. Rheumatology (Oxford) 44 (2005) 187-191
26. Buyon J.P., Tseng C.E., Di Donato F., et al. Cardiac expression of 52beta, an alternative transcript of the congenital heart block-associated 52-kd SS-A/Ro autoantigen, is maximal during fetal development. Arthritis Rheum. 40 (1997) 655-660
27. Buyon J.P., and Clancy R.M. Autoantibody-associated congenital heart block: TGF-beta and the road to scar. Autoimmun. Rev. 4 (2005) 1-7
28. Cimaz R, Borghi MO, Gerosa M, et al. Transforming growth factor-β1 in the pathogenesis of autoimmune complete congenital heart block: lesson from twins and triplets discordant for the disease. Arthritis Rheum 2006 (a paraître).
29. Clancy R.M., Backer C.B., Yin X., et al. Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-alpha and TGF-beta 1 to the pathogenesis of autoimmune-associated congenital heart block. J. Immunol. 171 (2003) 3253-3261
30. Buyon J.P., Hiebert R., Copel J., et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J. Am. Coll. Cardiol. 31 (1998) 1658-1666
31. Eronen M., Siren M.K., Ekblad H., et al. Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn. Pediatrics 106 (2000) 86-91
32. Cimaz R. Any increased risk of autoimmune disease?. Lupus 13 (2004) 736-739
33. Press J., Uziel Y., Laxer R.M., et al. Long-term outcome of mothers of children with complete congenital heart block. Am. J. Med. 100 (1996) 328-332
34. Julkunen H., and Eronen M. Long-term outcome of mothers of children with isolated heart block in Finland. Arthritis Rheum. 44 (2001) 647-652
35. Julkunen H., Kurki P., Kaaja R., et al. Isolated congenital heart block. Long-term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La. Arthritis Rheum. 36 (1993) 1588-1598
36. Brucato A., Franceschini F., Gasparini M., et al. Isolated congenital complete heart block: longterm outcome of mothers, maternal antibody specificity and immunogenetic background. J. Rheumatol. 22 (1995) 533-540
37. Julkunen H., and Eronen M. The rate of recurrence of isolated congenital heart block: a population-based study. Arthritis Rheum. 44 (2001) 487-488
38. Saleeb S., Copel J., Friedman D., et al. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum. 42 (1999) 2335-2345
39. Groves A.M., Allan L.D., and Rosenthal E. Therapeutic trial of sympathomimetics in three cases of complete heart block in the fetus. Circulation 92 (1995) 3394-3396